Lv1
20 积分 2023-10-07 加入
Minimal Residual Disease–Based End Point for Accelerated Assessment of Clinical Trials in Multiple Myeloma: A Pooled Analysis of Individual Patient Data From Multiple Randomized Trials
1小时前
待确认
Minimal residual disease in multiple myeloma
3小时前
已完结
Heme promotes venetoclax resistance in multiple myeloma through MEK-ERK signaling and purine biosynthesis
2个月前
已完结
Extracellular vesicles from the lung pro-thrombotic niche drive cancer-associated thrombosis and metastasis via integrin beta 2
2个月前
已完结
Fatty acid binding proteins in multiple myeloma
2个月前
已完结
Discovery of Potent, Selective, and Orally Available IRE1α Inhibitors Demonstrating Comparable PD Modulation to IRE1 Knockdown in a Multiple Myeloma Model
3个月前
已完结
Real world analysis on the determinants of survival in primary plasma cell leukemia in the United States
4个月前
已完结
CAR T Cells and T-Cell Therapies for Cancer: A Translational Science Review
4个月前
已完结
FABP5+ lipid-loaded macrophages process tumour-derived unsaturated fatty acid signal to suppress T-cell antitumour immunity
4个月前
已完结
Mechanisms of resistance against T-cell engaging bispecific antibodies in multiple myeloma: implications for novel treatment strategies
4个月前
已完结
皖公网安备34019202002308
